We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$8.84B
AUM Growth
+$364M
Cap. Flow
+$48.9M
Cap. Flow %
0.55%
Top 10 Hldgs %
21.07%
Holding
122
New
10
Increased
61
Reduced
44
Closed
6

Top Buys

Rank Stock Value
1
EG icon
Everest Group
EG
+$81.5M
2
OKTA icon
Okta
OKTA
+$63.5M
3
EW icon
Edwards Lifesciences
EW
+$55.1M
4
ULTA icon
Ulta Beauty
ULTA
+$54.6M
5
TAP icon
Molson Coors Class B
TAP
+$47.7M

Sector Composition

Rank Sector Weight
1 Healthcare 21.37%
2 Technology 18.39%
3 Industrials 15.93%
4 Consumer Staples 14.78%
5 Financials 14.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNCE
1
DELISTED
Snyders-Lance, Inc.
LNCE
$233M 2.63%
4,642,990
-1,285,285
-22% -$51M
WLY icon
2
John Wiley & Sons Class A
WLY
$2.77B
$225M 2.54%
3,416,750
-6,775
-0.2% -$392K
IART icon
3
Integra LifeSciences
IART
$1.45B
$222M 2.52%
4,646,075
+110,355
+2% +$5.4M
BLKB icon
4
Blackbaud
BLKB
$1.82B
$201M 2.28%
2,132,405
-241,790
-10% -$23.3M
RBA icon
5
RB Global
RBA
$21.5B
$183M 2.07%
6,100,585
+469,370
+8% +$13.1M
WEX icon
6
WEX
WEX
$6.27B
$171M 1.93%
1,207,825
-51,400
-4% -$6.43M
NUVA
7
DELISTED
NuVasive, Inc.
NUVA
$168M 1.9%
2,866,247
+171,455
+6% +$9.72M
LOGM
8
DELISTED
LogMein, Inc.
LOGM
$156M 1.77%
1,364,460
-8,245
-0.6% -$969K
THS
9
DELISTED
Treehouse Foods
THS
$155M 1.75%
3,135,190
+182,965
+6% +$9.79M
ATR icon
10
AptarGroup
ATR
$8.61B
$149M 1.69%
1,727,600
+129,205
+8% +$11.3M
RHT
11
DELISTED
Red Hat Inc
RHT
$145M 1.64%
1,204,005
+11,385
+1% +$1.4M
NDSN icon
12
Nordson
NDSN
$16.7B
$143M 1.61%
974,340
+7,555
+0.8% +$971K
HRL icon
13
Hormel Foods
HRL
$14.2B
$134M 1.52%
3,684,235
+524,325
+17% +$17.6M
PB icon
14
Prosperity Bancshares
PB
$8.8B
$133M 1.5%
1,892,150
+38,115
+2% +$2.55M
NTRS icon
15
Northern Trust
NTRS
$22.3B
$131M 1.48%
1,313,490
+12,195
+0.9% +$1.16M
SPLK
16
DELISTED
Splunk Inc
SPLK
$130M 1.47%
1,564,140
+15,000
+1% +$1.1M
CTLT
17
DELISTED
CATALENT, INC.
CTLT
$125M 1.41%
3,043,715
+298,015
+11% +$12.1M
LH icon
18
Labcorp
LH
$25.6B
$122M 1.38%
888,586
+10,092
+1% +$1.33M
WAB icon
19
Wabtec
WAB
$50.9B
$120M 1.36%
1,474,740
+21,930
+2% +$1.68M
XRAY icon
20
Dentsply Sirona
XRAY
$2.76B
$118M 1.34%
1,793,485
+20,010
+1% +$1.27M
MDSO
21
DELISTED
Medidata Solutions, Inc.
MDSO
$118M 1.33%
1,856,985
+163,045
+10% +$11.6M
FLO icon
22
Flowers Foods
FLO
$1.61B
$117M 1.32%
6,054,595
+87,200
+1% +$1.67M
GWRE icon
23
Guidewire Software
GWRE
$13.3B
$117M 1.32%
1,572,665
-561,100
-26% -$43.3M
WWW icon
24
Wolverine World Wide
WWW
$1.68B
$115M 1.3%
3,611,710
-463,440
-11% -$13.4M
PANW icon
25
Palo Alto Networks
PANW
$259B
$113M 1.28%
4,676,010
+38,550
+0.8% +$938K

Similar funds

Champlain Investment Partners's Q4 2017 Portfolio in Review

As of Q4 2017, Champlain Investment Partners held 122 positions worth $8.84B, up 4.3% from $8.47B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Champlain Investment Partners's Q4 2017 filing shows 10 new, 61 increased, 44 reduced and 6 closed positions. Its largest new stake was Everest Group: 361,505 shares worth $80M. The largest sale was Align Technology, an estimated $83.1M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.

  • Champlain Investment Partners's largest Q4 2017 buy was Everest Group: 361,505 shares worth $80M.
  • Champlain Investment Partners added most to Okta in Q4 2017, an estimated $63.5M increase.
  • Champlain Investment Partners's biggest Q4 2017 reduction was Snyders-Lance, Inc., cutting an estimated $51M.
  • Champlain Investment Partners fully exited Align Technology in Q4 2017, selling an estimated $83.1M.
  • Champlain Investment Partners's ten largest holdings make up 21% of its $8.84B portfolio in Q4 2017.
  • Champlain Investment Partners opened 10 new positions and closed 6 in Q4 2017.
  • Champlain Investment Partners's portfolio value rose 4.3% quarter-over-quarter to $8.84B.

Based on Champlain Investment Partners's 13F filing for Q4 2017, filed 12 Feb 2018.